Correlation between thyroid hormone levels and cognitive dysfunction in older patients with subclinical hypothyroidism
Wiener klinische Wochenschrift · 2026-10 · 138 (19-20) · 623-631
DOI: 10.1007/s00508-026-02729-5 ↗Kurz gefasst
Fachartikel in der Zeitschrift Wiener klinische Wochenschrift, online erschienen am 18.03.2026. Verfasst von Haiyan Zheng und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology, Renmin Hospital, Hubei University of Medicine, Shiyan, Hubei, 442000, China. Hauptthemen laut MEDLINE: Hypothyroidism, Cognitive Dysfunction, Thyroid Hormones. Die Arbeit nennt 34 Literaturangaben.
Abstract (Originalsprache)
OBJECTIVE: To investigate the correlation between thyroid hormone levels and cognitive dysfunction in older patients with subclinical hypothyroidism (SCH). METHODS: A retrospective matched case-control study (1:2 ratio) was conducted, enrolling 420 participants aged ≥ 60 years (140 SCH cases, 280 euthyroid controls) matched by gender, age (± 5 years) and education level. Thyroid function parameters, including thyroid-stimulating hormone (TSH), free triiodothyronine (FT3), free thyroxine (FT4), thyroid peroxidase antibody (TPOAb), and thyroglobulin antibody (TgAb), and cognitive performance assessed via the Mini-Mental State Examination (MMSE), Montreal Cognitive Assessment (MoCA), Alzheimer's Disease Assessment Scale-Cognitive Subscale (ADAS-Cog), Auditory Verbal Learning Test (AVLT), Trail Making Test (TMT), and Stroop Color and Word Test (Stroop Test) were measured. RESULTS: The SCH patients had TSH levels consistent with the grouping criteria (TSH > 4.2 mIU/L), higher thyroid autoantibody positivity, and poorer cognitive performance across all domains (all P < 0.001). A dose-response relationship was observed between increasing TSH levels and worsening cognitive function. Multivariate logistic regression identified TSH (odds ratio, OR = 1.19), FT3 (OR = 0.68), age, education and APOE ε4 carrier status as independent predictors of cognitive impairment (ROC AUC = 0.786). Stratified analyses showed stronger associations in females and those aged < 75 years, whereas the significance of the correlation between TSH and cognitive impairment was lost in patients aged ≥ 75 years. Sensitivity analyses confirmed the robustness of the findings. CONCLUSION: The SCH is independently associated with cognitive dysfunction in older people, with thyroid hormones playing a critical role. The findings suggest potential clinical implications for thyroid function monitoring and cognitive protection in this population.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Endocrinology, Renmin Hospital, Hubei University of Medicine, Shiyan, Hubei, 442000, China.
- Department of Endocrinology, Renmin Hospital, Hubei University of Medicine, Shiyan, Hubei, 442000, China. wangqian87876@163.com.
Zitieren
APA
Zheng, H., Si, M., & Wang, Q. (2026). Correlation between thyroid hormone levels and cognitive dysfunction in older patients with subclinical hypothyroidism. Wiener klinische Wochenschrift, 138(19-20), 623-631. https://doi.org/10.1007/s00508-026-02729-5
Vancouver
Zheng H, Si M, Wang Q. Correlation between thyroid hormone levels and cognitive dysfunction in older patients with subclinical hypothyroidism. Wiener klinische Wochenschrift. 2026;138(19-20):623-631. doi:10.1007/s00508-026-02729-5
BibTeX
@article{Zheng2026,
author = {Zheng, Haiyan and Si, Min and Wang, Qian},
title = {Correlation between thyroid hormone levels and cognitive dysfunction in older patients with subclinical hypothyroidism},
journal = {Wiener klinische Wochenschrift},
year = {2026},
volume = {138},
number = {19-20},
pages = {623--631},
doi = {10.1007/s00508-026-02729-5}
}
EUVIMED